Candel Therapeutics To Join Russell 3000 Index, Effective At The Open Of Us Equity Markets On Monday, July 1, 2024
Portfolio Pulse from Benzinga Newsdesk
Candel Therapeutics (NASDAQ:CADL) will join the Russell 3000 Index effective July 1, 2024, as part of the annual reconstitution of the Russell US Indexes.
June 11, 2024 | 12:22 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Candel Therapeutics will be added to the Russell 3000 Index, which could increase its visibility and attract more institutional investors.
Inclusion in the Russell 3000 Index typically leads to increased visibility and can attract institutional investors, potentially driving up the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100